Yassamine Lazrek, Olivier Dubreuil, Véronique Garambois, Nadège Gaborit, Christel Larbouret, et al.. Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.: Anti-HER3 antibodies in cancer therapy.
Neoplasia : An International Journal for Oncology Research, Elsevier, 2013, 15 (3), pp.335-47.
⟨10.1593/neo.121960⟩.
⟨inserm-00815985⟩